期刊文献+

痛风患者载脂蛋白C-Ⅲ启动子C-482T和T-455C的单核苷酸多态性与脂代谢紊乱

The relationship between C-482T and T-455C single nucleotide polymorphism in ApoC-Ⅲ and high triglyceride of gout patients
原文传递
导出
摘要 目的通过研究痛风患者载脂蛋白C-Ⅲ(ApoC-Ⅲ)启动子的单核苷酸多态性与高甘油三酯(HTG)血症之间的关系,探讨该基因变异与痛风病程进展的关系。方法测定中国山东地区300例痛风患者及300例健康人群中的ApoC-Ⅲ启动子的两个位点C-482T和T-455C的基因型和等位基因频率,同时测定两组人群的血脂水平,并对其进行比较。结果痛风组较对照组TG水平增高,差异有统计学意义(t=6.75,P<0.01)。455位点的CC、CT和TT基因型在痛风组和对照组中分布频率分别为23.0%、24.0%、53.0%和30.3%、13.3%、56.3%,差异有统计学意义(χ2=12.47,P<0.01);455位点等位基因C的分布频率在痛风组和对照组中49.5%和58.5%,差异有显著性统计学意义(χ2=9.78,P<0.01);482位点的CC、CT和TT基因型在痛风组和对照组中分布频率分别为28.0%、23.0%、49.0%和16.0%、33.7%、50.3%,差异有显著性统计学意义(χ2=15.89,P<0.01);482位点等位基因T的分布频率在痛风组和对照组中47.5%和58.8%,差异有统计学意义(χ2=15.47,P<0.01)。结论 ApoC-Ⅲ启动子的455和482位点的基因多态性与痛风患者的HTG发病有关。 Objective To study the relationship between single nucleotide polymorphism of promoter apolipoprotein C-III (ApoC-III) and high triglyceride (HTG) of the gout patients, to explore the relationship between the gene mutation and gout disease. Methods Two promoter loci C-482T and T-455C genotype in ApoC-III in 300 gout patients and 300 healthy control in Shandong province of China were determinated, blood lipid levels were also determined in the two groups, and then compared. Results The level of TG in gout group were higher than healthy control (t=6.75, P〈0.01); there was significant difference between gout group and healthy control in loci 455, CC CT TT were 23.0%, 24.0%, 53.0% in gout group, and 30.3%, 13.3%, 56.3% in healthy control (Z2= 12.47, P〈0.01). The frequency distribution of gene C in loci 455 were respectively 49.5% and 58.5% in gout group and healthy control (x2 = 15.89, P〈0.01); there was significant difference between gout group and healthy control in loci 482, CC CT TT were 28.0%, 23.0%, 49.0% in gout group, and 16.0%, 33.7%, 50.3% in healthy control(x2= 15.89, P〈0.01). The frequency distribution of gene C in loci 482 were respectively 47.5% and 58.8% in gout group and healthy control (x2=15.47, P〈0.01). Conclusion There were relationship between gene promoter 455 and 482 polymorphism in ApoC-III and the pathogenesis of HTG in gout patients.
出处 《中华临床医师杂志(电子版)》 CAS 2013年第19期48-50,共3页 Chinese Journal of Clinicians(Electronic Edition)
关键词 载脂蛋白CIII 痛风 高甘油三酯血症 单核苷酸多态性 Apolipoprotein C-III Gout Hypertriglyceridemia Single nucleotide polymorphism
  • 相关文献

参考文献12

  • 1Juntti-Berggren L,Refai E,Appelskog I. Apolipoprotein CⅢpromotes Ca2+ dependent beta cell death in type 1 diabetes[J].Proceedings of the National Academy of Sciences(USA),2004.10090-10094.
  • 2Shin MJ,Blanche PJ,Rawlings RS. Increased plasma concentrations of lipoprotein(a)during a low-fat,high-carbohydrate diet are associated with increased plasma concentrations of apolipoprotein C-Ⅲ bound to apolipoprotein B-containing lipoproteins[J].American Journal of Clinical Nutrition,2007.1527-1532.
  • 3Dinkel RE,Barrett PH,Demant T. In-vivo metabolism of VLDL-apolipoprotein-B,-CⅢ and-E in normolipidemic subjects[J].Nutrition Metabolism and Cardiovascular Diseases,2006.215-221.
  • 4Fiegenhaum M,de-Andrade FM,Hutz MH. Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects:effect of gender,smoking and APOE genotypes[J].Clinica Chimica Acta,2007.175-181.
  • 5Mendivil CO,Rimm EB,Furtado J. Apolipoprotein E in VLDL and LDL with apolipoprotein C-Ⅲ is associated with a lower risk of coronary heart disease[J].J Am Heart Assoc,2013.e000130.
  • 6Masana L,Febrer G,Cavanna J. Common genetic variants that relate to disorders of lipid transport in Spanish subjects with premature coronary artery disease[J].Clin Sci(Lond),2001.183-190.
  • 7Souverein OW,Jukema JW,Boekholdt SM. Polymorphisms in APOA1 and LPL genes are statistically independently associated with fasting TG in men with CAD[J].European Journal of Human Genetics,2005.445-451.
  • 8Cardona F,Tinahones FJ,Col antes E. Contribution of polymorphisms in the apolipoprotein AI-CⅢ-AIV cluster to hyperlipidaemia in patients with gout[J].ANNALS OF THE RHEUMATIC DISEASES,2005.85-88.
  • 9Watts GF,Ooi EM,Chan DC. Demystifying the management of hypertriglyceridaemia[J].Nat Rev Cardiol,2013.648-661.
  • 10Jensen MK,Rimm EB,Furtado JD. Apolipoprotein C-Ⅲ as a potential modulator of the association between HDL-cholesterol and incident coronary heart disease[J].J Am Heart Assoc,2012.jah3-e000232.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部